GSN and urinary bladder cancer: A review of prior studies revealed that activating transcription factor 3 (ATF3) was identified as an upstream transcriptional regulator of GSN in bladder cancer, modulating its transcription.[34] ATF3 is a critical transcription factor involved in liver metabolic diseases.